Related references
Note: Only part of the references are listed.Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases Further Evidence for the Tubal Origin of High-grade Serous Carcinomas
C. Blake Gilks et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Beyond genomics: Critical evaluation of cell line utility for ovarian cancer research
Kevin M. Elias et al.
GYNECOLOGIC ONCOLOGY (2015)
Assessment of a new system for primary site assignment in high-grade serous carcinoma of the fallopian tube, ovary, and peritoneum
Naveena Singh et al.
HISTOPATHOLOGY (2015)
CUB-domain-containing protein 1 overexpression in solid cancers promotes cancer cell growth by activating Src family kinases
C. Leroy et al.
ONCOGENE (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
EGF inhibits constitutive internalization and palmitoylation-dependent degradation of membrane-spanning procancer CDCP1 promoting its availability on the cell surface
M. N. Adams et al.
ONCOGENE (2015)
Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells
Q. Cai et al.
ONCOGENE (2015)
Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
Catherine Emmanuel et al.
CLINICAL CANCER RESEARCH (2014)
A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
Cheryl A. Sherman-Baust et al.
JOURNAL OF PATHOLOGY (2014)
In vivo cleaved CDCP1 promotes early tumor dissemination via complexing with activated β1 integrin and induction of FAK/PI3K/Akt motility signaling
B. Casar et al.
ONCOGENE (2014)
Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
Corine M. Beaufort et al.
PLOS ONE (2014)
Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids
Mark Desjardins et al.
JOURNAL OF OVARIAN RESEARCH (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Ruth Perets et al.
CANCER CELL (2013)
Isolation and Phenotypic Characterization of Colorectal Cancer Stem Cells With Organ-Specific Metastatic Potential
Wenchao Gao et al.
GASTROENTEROLOGY (2013)
Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy
Gwendlyn Kollmorgen et al.
MOLECULAR ONCOLOGY (2013)
Latest research and treatment of advanced-stage epithelial ovarian cancer
Robert L. Coleman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation
Jane E. Armes et al.
PATHOLOGY (2013)
Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
Michael S. Anglesio et al.
PLOS ONE (2013)
Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients
Brooke M. Emerling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Evaluating cell lines as tumour models by comparison of genomic profiles
Silvia Domcke et al.
NATURE COMMUNICATIONS (2013)
The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell Migration
Ying Dong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Blocking of CDCP1 cleavage in vivo prevents Akt-dependent survival and inhibits metastatic colonization through PARP1-mediated apoptosis of cancer cells
B. Casar et al.
ONCOGENE (2012)
Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
Gwendlyn Kollmorgen et al.
PLOS ONE (2012)
High-grade serous ovarian cancer arises from fallopian tube in a mouse model
Jaeyeon Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cellular Settings Mediating Src Substrate Switching between Focal Adhesion Kinase Tyrosine 861 and CUB-domain-containing protein 1 (CDCP1) Tyrosine 734
Andreas Wortmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
Anna Yemelyanova et al.
MODERN PATHOLOGY (2011)
Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis
W. Glenn McCluggage
PATHOLOGY (2011)
Humanized Mouse Model of Ovarian Cancer Recapitulates Patient Solid Tumor Progression, Ascites Formation, and Metastasis
Richard B. Bankert et al.
PLOS ONE (2011)
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma
Hui Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
VHL loss in renal cell carcinoma leads to up-regulation of CUB domain-containing protein 1 to stimulate PKCδ-driven migration
Olga V. Razorenova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
Melissa S. DeRycke et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Ovarian Cancer Development and Metastasis
Ernst Langyel
AMERICAN JOURNAL OF PATHOLOGY (2010)
CUB Domain-Containing Protein 1, a Prognostic Factor for Human Pancreatic Cancers, Promotes Cell Migration and Extracellular Matrix Degradation
Yuri Miyazawa et al.
CANCER RESEARCH (2010)
Proteolysis-induced N-terminal Ectodomain Shedding of the Integral Membrane Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Is Accompanied by Tyrosine Phosphorylation of Its C-terminal Domain and Recruitment of Src and PKCδ
Yaowu He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
Martin Koebel et al.
JOURNAL OF PATHOLOGY (2010)
Inhibition of Tumor Metastasis: Functional Immune Modulation of the CUB Domain Containing Protein 1
Keisuke Fukuchi et al.
MOLECULAR PHARMACEUTICS (2010)
Expression of CUB domain containing protein (CDCP1) is correlated with prognosis and survival of patients with adenocarcinoma of lung
Jun-ichiro Ikeda et al.
CANCER SCIENCE (2009)
The Cell Surface Glycoprotein CDCP1 in Cancer-Insights, Opportunities, and Challenges
Andreas Wortmann et al.
IUBMB LIFE (2009)
Functional Role of Cell Surface CUB Domain-Containing Protein 1 in Tumor Cell Dissemination
Elena I. Deryugina et al.
MOLECULAR CANCER RESEARCH (2009)
CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma
Takamasa Uekita et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model
Amara C. Siva et al.
CANCER RESEARCH (2008)
Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma
Yasuo Awakura et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma
M Al-Hussaini et al.
HISTOPATHOLOGY (2004)
Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen
JD Hooper et al.
ONCOGENE (2003)
Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer
A Obermair et al.
GYNECOLOGIC ONCOLOGY (2001)
Share Paper
